IPA Submits Comments to CMS on CY 2026 Hospital Outpatient Proposed RuleInfusion Providers Alliance2025-09-18T18:35:15+00:00Read More
IPA Submits Comments to CMS on CY 2026 Physician Fee Schedule Proposed RuleInfusion Providers Alliance2025-09-18T19:54:11+00:00Read More
IPA Joins Patient & Provider Organizations in Support of Bipartisan Bill to Protect Patient Access to Cancer and Complex TherapiesInfusion Providers Alliance2025-09-04T17:02:26+00:00Read More
Infusion Providers Alliance Applauds Reintroduction of “The Protecting Patient Access to Cancer and Complex Therapies Act”Infusion Providers Alliance2025-07-09T19:59:13+00:00Read More
Infusion Providers Alliance Responds to Draft Guidance on Medicare Drug Price Negotiation ProgramInfusion Providers Alliance2025-07-03T15:45:12+00:00Read More
Infusion Providers Alliance Sends Letter to Aetna Opposing Specialty Pharmacy MandateInfusion Providers Alliance2025-07-03T16:56:33+00:00Read More
IPA Joins 40+ Patient and Provider Groups in Letters to Congress and the FTC Detailing Dynamics Impacting Access to BiosimilarsInfusion Providers Alliance2025-06-04T13:48:31+00:00Read More
The Infusion Providers Alliance is pleased to submit testimony to the Ways & Means Health SubcommitteeInfusion Providers Alliance2025-04-21T16:35:06+00:00Read More